SEC Form 4 · accession 0001127602-18-011705
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas C Zielinski
Officer — EVP & General Counsel
Period of report
Mar 13, 2018
Accepted (ET)
Mar 15, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 13, 2018 | M | 3,000 | $108.35 | A | 29,084 | D | |
| Common Stock | Mar 13, 2018 | M | 5,588 | $146.93 | A | 34,672 | D | |
| Common Stock | Mar 13, 2018 | M | 6,763 | $131.80 | A | 41,435 | D | |
| Common Stock | Mar 13, 2018 | M | 5,104 | $166.97 | A | 46,539 | D | |
| Common StockF1 | Mar 13, 2018 | S | 14,255 | $228.98 | D | 32,284 | D | |
| Common StockF2 | Mar 13, 2018 | S | 6,200 | $229.80 | D | 26,084 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $108.35 | Mar 13, 2018 | M | 3,000 | D | — | Jun 2, 2021 | Common Stock | 3,000 | 4,064 | D |
| Employee Stock Option (Right to Buy)F4 | $146.93 | Mar 13, 2018 | M | 5,588 | D | — | Mar 2, 2025 | Common Stock | 5,588 | 0 | D |
| Employee Stock Option (Right to Buy)F5 | $131.80 | Mar 13, 2018 | M | 6,763 | D | — | Mar 1, 2026 | Common Stock | 6,763 | 6,764 | D |
| Employee Stock Option (Right to Buy)F6 | $166.97 | Mar 13, 2018 | M | 5,104 | D | — | Mar 1, 2027 | Common Stock | 5,104 | 10,210 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $228.49 to $229.47. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $229.50 to $230.22. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The option represents a right to purchase a total of 21,191 shares, and is exercisable in six semi-annual installments with one installment of 3,531 shares and five installments of 3,532 shares each beginning on December 2, 2014, which is the six-month anniversary of the date on which the option was granted.
- F4The option, representing a right to purchase a total of 16,762 shares and is exercisable in six semi annual installments with two installments of 2,793 shares each and four installments of 2,794 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted.
- F5The option represents a right to purchase a total of 20,289 shares, and is exercisable in six semi-annual installments, with three installments of 3,381 shares each and three installments of 3,382 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.
- F6The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.